Filed by Nuveen Insured California Tax-Free Advantage Municipal Fund
pursuant to Rule 425 of the Securities Act of 1933, as amended
Subject Companies:
Nuveen Insured California Tax-Free Advantage Municipal Fund
Commission File No. 811-21212
Nuveen Insured California Premium Income Municipal Fund, Inc.
Commission File No. 811-06620
Nuveen Insured California Premium Income Municipal Fund 2, Inc.
Commission File No. 811-07492
Nuveen Insured California Dividend Advantage Municipal Fund
Commission File No. 811-09449
Closed-End Funds
NUVEEN CLOSED-END FUNDS PRODUCT UPDATE
FEBRUARY 2012
|
Nuveen California Municipal Closed-End Fund Merger
The funds will merge as outlined in the table on page 2.
NOT FDIC INSURED NO BANK GUARANTEE MAY LOSE VALUE
FOR FINANCIAL ADVISOR USE ONLY. NOT FOR DISTRIBUTION TO THE PUBLIC.
NUVEEN CALIFORNIA MUNICIPAL CLOSED-END FUND MERGER | FEBRUARY 2012 |
Acquiring Fund* |
Symbol |
Acquired Fund |
Symbol | |||||||||
Nuveen Insured California Tax-Free Advantage Municipal Fund |
NKX | Nuveen Insured California Premium Income Municipal Fund |
NPC | |||||||||
Nuveen Insured California Premium Income Municipal Fund 2 |
NCL | |||||||||||
Nuveen Insured California Dividend Advantage Municipal Fund |
NKL |
* | Upon shareholder approval of the investment policy changes, Nuveen Insured California Tax-Free Advantage Municipal Fund (NKX) will change its name to Nuveen California AMT-Free Municipal Income Fund (NKX). |
Thank you for your support of Nuveen closed-end funds. Should you have any further questions regarding the merger proposal or proxy process, please contact your Nuveen Service Team at 1-800-752-8700.
The joint proxy statement/prospectus related to the meeting, as well as the Annual and Semi-Annual Reports and other regulatory filings of the Nuveen closed-end funds filed with the Securities and Exchange Commission (SEC), are accessible for free on the SECs website at www.sec.gov and on Nuveens website at www.nuveen.com. The information contained on Nuveens website is not a part of this document.
This information does not constitute an offer for sale of any securities. Shareholders and their financial advisors are urged to read the joint proxy statement/prospectus carefully as it contains important information regarding the proposals. Investors should carefully consider their investment objectives, risk tolerance, liquidity needs and tax liabilities. There can be no assurance that any fund will achieve its investment objectives.
Nuveen Investments | 333 West Wacker Drive | Chicago, IL 60606 | 800.752.8700 | www.nuveen.com